🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Camille Carroll

NIHR Newcastle Biomedical Research Centre

ORCID: 0000-0001-7472-953X

Also affiliated with Newcastle University

MedicineEconomics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study”.

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Neurology and Therapy(2023)10.1007/s40120-023-00533-1

N/A

5.3DataRank · unranked

122 citations

Eric Freire-Álvarez, А. В. Амелин, Angelo Antonini, Bruno Bergmans, Filip Bergquist +17 more

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop

Journal of Parkinson's Disease(2020)10.3233/jpd-202004

N/A

3.5DataRank · unranked

135 citations

Anders Björklund, Don M. Gash, Alan Whone, Amber Van Laar, Jeffrey H. Kordower +26 more

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

The Lancet(2025)10.1016/s0140-6736(24)02808-3

N/A

2.3DataRank · unranked

131 citations

Christine Girges, Grace Auld, Rachel McComish, Alexa King, Simon S. Skene +32 more

Genome-wide Analysis of Motor Progression in Parkinson Disease

Neurology Genetics(2023)10.1212/nxg.0000000000200092

N/A

0.345DataRank · unranked

9 citations

Raquel Real, Michael Lawton, Regina Hertfelder Reynolds, Manuela Tan, Lesley Wu +16 more

Association of genetic variation at the GJA5/ACP6 locus with motor progression in Parkinson’s

medRxiv(2022)10.1101/2022.10.28.22281645

N/A

0DataRank · unranked

1 citations

Raquel Real, Michael Lawton, Regina Hertfelder Reynolds, Manuela Tan, Lesley Wu +11 more

Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?

Parkinsonism & Related Disorders(2021)10.1016/j.parkreldis.2021.07.032

N/A

0DataRank · unranked

60 citations

Jirada Sringean, Dhaval Trivedi, Camille Carroll, Anette Schrag, Per Odin +5 more

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

npj Parkinson s Disease(2023)10.1038/s41531-023-00573-2

N/A

0DataRank · unranked

12 citations

Raquel Real, Michael Lawton, Hirotaka Iwaki, Manuela Tan, Lesley Wu +11 more

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

medRxiv(2023)10.1101/2023.05.24.23290362

N/A

0DataRank · unranked

2 citations

Raquel Real, Michael Lawton, Hirotaka Iwaki, Manuela Tan, Lesley Wu +11 more

Early Detection of Alzheimer's Disease with Blood Plasma Proteins Using Support Vector Machines

IEEE Journal of Biomedical and Health Informatics(2020)10.1109/jbhi.2020.2984355

N/A

0DataRank · unranked

121 citations

Emmanuel Jammeh, Xinzhong Li, Camille Carroll, Stephen Pearson, Emmanuel Ifeachor +1 more